{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:22:14Z","timestamp":1778588534098,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Forest Research Institute"},{"name":"NIH","award":["R01DK056843"],"award-info":[{"award-number":["R01DK056843"]}]},{"name":"NIH Institutional Training Grants","award":["T32DK076541"],"award-info":[{"award-number":["T32DK076541"]}]},{"name":"NIH Institutional Training Grants","award":["T32HL083810"],"award-info":[{"award-number":["T32HL083810"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.lfs.2012.06.005","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T14:56:03Z","timestamp":1340117763000},"page":"54-63","source":"Crossref","is-referenced-by-count":13,"title":["Nebivolol does not protect against 5\/6 ablation\/infarction induced chronic kidney disease in rats \u2014 Comparison with angiotensin II receptor blockade"],"prefix":"10.1016","volume":"91","author":[{"given":"Jennifer M.","family":"Sasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha C.","family":"Moningka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsiana","family":"Tsarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Baylis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2012.06.005_bb0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2012.06.005_bb0010","first-page":"F1","article-title":"Nitric oxide deficiency in chronic kidney disease. Gottschalk Lecture 2007","volume":"294","author":"Baylis","year":"2008","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0015","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2012.06.005_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.niox.2008.03.004","article-title":"Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits","volume":"19","author":"de Nigris","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.lfs.2012.06.005_bb0025","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.104.532960","article-title":"Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol","volume":"112","author":"Dessy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2012.06.005_bb0030","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1097\/01.ASN.0000086476.48686.7D","article-title":"Protection of Wistar-Furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase","volume":"14","author":"Erdely","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.phrs.2007.09.015","article-title":"Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity","volume":"56","author":"Garbin","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.lfs.2012.06.005_bb0035","doi-asserted-by":"crossref","first-page":"367590","DOI":"10.1155\/2008\/367590","article-title":"Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells","volume":"2008","author":"Garbin","year":"2008","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.lfs.2012.06.005_bb0205","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI2191","article-title":"The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle","volume":"102","author":"Gauthier","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2012.06.005_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2004.11.043","article-title":"The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery","volume":"508","author":"Georgescu","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0050","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1681\/ASN.V4122023","article-title":"Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury","volume":"4","author":"Griffin","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.lfs.2009.07.006","article-title":"Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure","volume":"85","author":"Gschwend","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.06.005_bb0060","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1210\/en.2010-1038","article-title":"Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats","volume":"152","author":"Habibi","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2012.06.005_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000278757","article-title":"Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats","volume":"31","author":"Hayden","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/08038020410016557","article-title":"Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker","volume":"1","author":"Ignarro","year":"2004","journal-title":"Blood Press Suppl"},{"key":"10.1016\/j.lfs.2012.06.005_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1527-3466.2008.00044.x","article-title":"Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol","volume":"26","author":"Ignarro","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.lfs.2012.06.005_bb0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/HYPERTENSIONAHA.107.094458","article-title":"Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation","volume":"50","author":"Maffei","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2012.06.005_bb0085","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.ATV.0000065234.70518.26","article-title":"Nebivolol prevents vascular eNOS uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells","volume":"23","author":"Mollnau","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mad.2010.10.004","article-title":"Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase","volume":"132","author":"Moningka","year":"2011","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.lfs.2012.06.005_bb0095","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/ndt\/gfr449","article-title":"Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade","volume":"27","author":"Moningka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lfs.2012.06.005_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14779072.1.1.51","article-title":"The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease","volume":"1","author":"Norris","year":"2003","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.lfs.2012.06.005_bb0105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.HYP.0000239207.82326.29","article-title":"Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II treated rats","volume":"48","author":"Oelze","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2012.06.005_bb0110","first-page":"383","article-title":"Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus","volume":"7","author":"O\u011fuz","year":"2007","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.lfs.2012.06.005_bb0115","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ajh.2008.260","article-title":"Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients","volume":"21","author":"Pasini","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.lfs.2012.06.005_bb0120","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1097\/HJH.0b013e3282efeecb","article-title":"Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction","volume":"25","author":"Pires","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.lfs.2012.06.005_bb0125","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.lfs.2007.04.016","article-title":"Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum","volume":"80","author":"Reidenbach","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.06.005_bb0130","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2008.11.057","article-title":"Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart","volume":"53","author":"Rozec","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0135","first-page":"R740","article-title":"Asymmetric dimethylarginine in angiotensin II induced hypertension","volume":"298","author":"Sasser","year":"2010","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/HYPERTENSIONAHA.110.164392","article-title":"Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(\u03c9)-nitro-l-arginine methyl ester hypertensive rats","volume":"58","author":"Sasser","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2012.06.005_bb0145","first-page":"371","article-title":"Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X","volume":"9","author":"Sen","year":"2009","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.lfs.2012.06.005_bb0150","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/ndt\/gfn676","article-title":"Splice variants of neuronal nitric oxide synthase are present in the rat kidney","volume":"24","author":"Smith","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lfs.2012.06.005_bb0155","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ki.1995.411","article-title":"Acute changes in urinary excretion of nitrite+nitrate (UNOXV) do not predict renal vascular NO production","volume":"48","author":"Suto","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2012.06.005_bb0160","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1046\/j.1523-1755.2003.00260.x","article-title":"Renal neuronal nitric oxide synthase protein expression as a marker of renal function","volume":"64","author":"Szabo","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.lfs.2012.06.005_bb0165","first-page":"F1404","article-title":"Vitamin E reduces glomerulosclerosis, restores renal nNOS and suppresses oxidative stress in the 5\/6 nephrectomized rat","volume":"292","author":"Tain","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.niox.2007.10.001","article-title":"Sex differences in response to rapamycin in kidney transplantation: impact on constitutive nitric oxide synthase","volume":"18","author":"Tain","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.lfs.2012.06.005_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pedneo.2011.02.007","article-title":"Reciprocal changes of renal neuronal nitric oxide synthase-\u03b1 and \u2010\u03b2 associated with renal progression in a neonatal 5\/6 nephrectomized rat model","volume":"52","author":"Tain","year":"2011","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0180","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/HJH.0b013e328349064c","article-title":"Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats","volume":"29","author":"Toblli","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.lfs.2012.06.005_bb0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1159\/000321471","article-title":"Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol","volume":"32","author":"Varagic","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vph.2010.12.001","article-title":"The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats","volume":"54","author":"Wang","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000229305","article-title":"Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat","volume":"30","author":"Whaley-Connell","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.lfs.2012.06.005_bb0200","first-page":"F996","article-title":"Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function","volume":"280","author":"Xiao","year":"2001","journal-title":"Am J Physiol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512003001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512003001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T23:17:06Z","timestamp":1642547826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320512003001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0024320512003001"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2012.06.005","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}